The immune response against herpesvirus is more prominent in the early stages of MS

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neurology

• Publication date

  2003-06-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/01.WNL.0000069461.53733.F7PMID 12821737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pubertal Growth Assessment

  2003cited by this paper
• Assessment of different treatment failure criteria in a cohort of relapsing–remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials

  2002cited by this paper
• Chlamydia pneumoniae and multiple sclerosis: no significant association.

  2001cited by this paper
• Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.

  2001cited by this paper
• Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS

  2001cited by this paper
• Multiple sclerosis: Genomic rewards

  2001cited by this paper
• Multiple sclerosis: a two-stage disease

  2001cited by this paper
• Autoimmune diseases.

  2001cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• Autoimmune diseases

  2000cited by this paper
• Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

  2000cited by this paper
• Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.

  2000cited by this paper
• Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease.

  2000cited by this paper
• Outbreaks of human-herpes virus 6 (HHV-6) infection in day-care centers in Belém, Pará, Brazil.

  2000cited by this paper
• The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach.

  2000cited by this paper
• Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group.

  2000cited by this paper
• Association between clinical disease activity and Epstein–Barr virus reactivation in MS

  2000cited by this paper
• Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS

  2000cited by this paper
• Viruses and Multiple Sclerosis

  2000cited by this paper
• Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity.

  1999cited by this paper
• Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis

  1999cited by this paper
• Give us this day our daily germs.

  1998cited by this paper
• Give us this day our daily germs.

  1998cited by this paper
• A single subtype of Epstein–Barr virus in members of multiple sclerosis clusters

  1998cited by this paper
• The significance of Epstein—Barr virus seropositivity in multiple sclerosis patients?

  1998influential reference
• Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

  1997cited by this paper
• Selected reviews common childhood and adolescent infections and multiple sclerosis.

  1997cited by this paper
• Common childhood and adolescent infections and multiple sclerosis

  1997cited by this paper
• Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA

  1997cited by this paper
• Epitope spreading

  1996cited by this paper
• The search for virus in multiple sclerosis brain

  1996cited by this paper
• Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.

  1995cited by this paper
• [Detection of Chlamydia pneumoniae by polymerase chain reaction].

  1993cited by this paper
• Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction.

  1993cited by this paper
• Pathogenesis of Multiple Sclerosis—The Immune Diathesis and the Role of Viruses

  1993cited by this paper
• Detection of Chlamydia pneumoniae by polymerase chain reaction

  1992cited by this paper

• HHV-6 and EBV reactivation in relapsing remitting multiple sclerosis: Disability, progression, and inflammation links

  2025cites this paper
• From Viral Infection to Autoimmune Reaction: Exploring the Link between Human Herpesvirus 6 and Autoimmune Diseases

  2024cites this paper
• Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis

  2023cites this paper
• Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review.

  2023cites this paper
• Human Herpesvirus 6A Is a Risk Factor for Multiple Sclerosis

  2022cites this paper
• Epidemiology of Multiple Sclerosis and Environmental Risk Factors

  2021cites this paper
• Herpesviruses and the hidden links to Multiple Sclerosis neuropathology.

  2021cites this paper
• Serum levels of matrix metalloproteinase-2, -9, and vitamin D in patients with multiple sclerosis with or without herpesvirus-6 seropositivity

  2020cites this paper
• Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation

  2020cites this paper
• MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients

  2020cites this paper
• The role of human herpesvirus-6 and inflammatory markers in the pathogenesis of multiple sclerosis.

  2020cites this paper
• Multiple Sclerosis is Caused by an Epstein Bar Virus Infection

  2020cites this paper
• Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis

  2019cites this paper
• Infectious agents and different course of multiple sclerosis: a systematic review

  2018cites this paper
• Estudio serológico del herpesvirus humano tipo 6 en pacientes con Esclerosis Múltiple

  2018cites this paper
• Association between human herpesvirus & human endogenous retrovirus and MS onset & progression.

  2017cites this paper
• The influence of sodium on pathophysiology of multiple sclerosis

  2017cites this paper
• Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review

  2017cites this paper
• Human herpesvirus 6, Varicella-Zoster virus and oligoclonal bands in demyelinating diseases of the central nervous system

  2016cites this paper
• HUMAN HERPESVIRUS 6 A AND 6 B : ASSAY VALIDATION , VIRUS-HOST INTERACTION AND CLINICAL RELEVANCE

  2016cites this paper
• Chlamydia Pneumoniae : The Potential Cause of Multiple Sclerosis

  2016cites this paper
• Epstein Barr Virus the Cause of Multiple Sclerosis

  2016cites this paper
• Biomarkers for phase switches in multiple sclerosis

  2015cites this paper
• Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review

  2015cites this paper
• Association of multiple sclerosis with Epstein-Barr virus infection.

  2015cites this paper
• HHV-6 and Multiple Sclerosis

  2014cites this paper
• Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy

  2014cites this paper
• Human herpesvirus 6 and the nervous system.

  2014cites this paper
• HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.

  2014cites this paper
• HUMAN HERPESVIRUS-6 IN MULTIPLE SCLEROSIS: ASSAY DEVELOPMENT, IMMUNE RESPONSES AND HOST GENETICS

  2013cites this paper
• Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis

  2013cites this paper
• Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis

  2012cites this paper
• No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome.

  2012cites this paper
• Original Article No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome

  2012cites this paper
• Murine gammaherpesvirus-68 elicits robust levels of interleukin-12 p40, but not interleukin-12 p70 production, by murine microglia and astrocytes

  2011cites this paper
• Herpesvirus active replication in multiple sclerosis: a genetic control?

  2011cites this paper
• Epstein–Barr virus and multiple sclerosis

  2011cites this paper
• Environmental Risk Factors for Paediatric Multiple Sclerosis

  2011cites this paper
• Review part 2: Human herpesvirus‐6 in central nervous system diseases

  2010cites this paper
• Human herpesvirus 6 infection as a trigger of multiple sclerosis.

  2010cites this paper
• Biomarkers for multiple sclerosis.

  2010cites this paper
• Epstein-Barr virus and multiple sclerosis.

  2009cites this paper
• Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis

  2009cites this paper
• Human herpesvirus 6 in multiple sclerosis and encephalitis

  2009cites this paper
• Reactivation of Human Herpesvirus-6 in Natalizumab Treated Multiple Sclerosis Patients

  2008cites this paper
• Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis.

  2008cites this paper
• Autoantigen− und erregerspezifische T− und B−Zell− reaktionen bei multipler Sklerose: (cid:185)Eine unendliche Geschichte“? Autoantigen− and Pathogen−Specific T− and B−Cell Responses in Multiple Sclerosis: A Never−Ending Story?

  2008cites this paper
• Viral Infection and Multiple Sclerosis

  2007cites this paper
• Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of multiple sclerosis.

  2007cites this paper
• An attempt to investigate the presence of Epstein Barr virus in multiple sclerosis and normal control brain tissue

  2007cites this paper
• Biochemical and immunological markers of multiple sclerosis

  2007cites this paper
• Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis?

  2007cites this paper
• Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive

  2007cites this paper
• Multipl Sklerozun Biyokimyasal ve İmmunolojik Belirteçleri) Invited Review (Çağrili Derleme)

  2007cites this paper
• Differential HHV‐6A gene expression in T cells and primary human astrocytes based on multi‐virus array analysis

  2006cites this paper
• High seroprevalence of Epstein–Barr virus in children with multiple sclerosis

  2006cites this paper
• Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life

  2006cites this paper
• Antibodies as biological markers for pathophysiological processes in MS.

  2006cites this paper
• [Infection by Epstein-Barr virus and multiple sclerosis].

  2006cites this paper
• Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis

  2006cites this paper
• Antibiotic use and risk of multiple sclerosis.

  2006cites this paper
• Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function

  2006cites this paper
• Exposure to infant siblings during early life and risk of multiple sclerosis.

  2005cites this paper
• Genes, environment, and susceptibility to multiple sclerosis.

  2004cites this paper
• Estudio de la osteopontina en la esclerosis múltiple y su relación con la progresión de la enfermedad

  2004cites this paper
• [Multiple sclerosis in the XXI century].

  2004cites this paper
• Biological markers of the inflammatory phase of multiple sclerosis

  2003cites this paper